Attorneys representing creditors of New England Compounding Pharmacy, a bankrupt Massachusetts custom drug maker tied to a fatal meningitis outbreak, are seeking to claw back more than $21 million, after revelations that owners pulled out funds in the year before the firm sought Chapter 11 protection.
Boston Business Journal